咪唑斯汀联合白芍总苷胶囊治疗慢性特发性荨麻疹临床疗效观察

目的：观察咪唑斯汀联合口服白芍总苷胶囊治疗慢性特发性荨麻疹的疗效。方法：选择120例慢性特发性荨麻疹患者，按就诊顺序分为两组，治疗组给予咪唑斯汀联合口服白芍总苷胶囊，对照组单一给予咪唑斯汀。结果：治疗结束时治疗组有效率为88％，对照组有效率为87％，两者之间差异无统计学意义；治疗结束后3个月治疗组复发率为43．37％，对照组复发率为71．20％，两者之间差异有统计学意义（P〈0．01）。结论：咪唑斯汀联合口服白芍总苷胶囊可能对慢性特发性荨麻疹治疗、预防复发有一定的作用。

Observation of therapeutic effect of mizolastine and total glucosides of paeony capsule on chronic idiopathic urticaria

AIM:To observe the therapeutic effect of mizolastine combined with total glucosides of paeony(TGP)capsule on chronic idiopathic urticaria.METHODS:According to treatment sequence,120 cases of chronic idiopathic urticaria patients were divided into two groups,the treatment group were given mizolastine and TGP,the control group only given mizolastine.RESULTS:The effective rates of the treatment group and the control group were 88%and 87%,respectively.There was no significant difference between the two groups;After 3 months,the relapse rates of the treatment group and the control group were 43.27%and 71.20%,respectively.There was significant difference between the two groups(P＜0.01).CONCLUSION:Mizolastine combined with TGP capsule may be effective for the treatment and preventing the relapse of chronic idiopathic urticaria.